Systematic Reviews and Meta-Analysis of Prognosis Research

Master

Online

£ 785 VAT inc.

Description

  • Type

    Master

  • Methodology

    Online

  • Duration

    3 Weeks

  • Online campus

    Yes

  • Delivery of study materials

    Yes

  • Support service

    Yes

  • Virtual classes

    Yes

The number of primary studies evaluating prognostic factors and models is rising per day. Alike for therapies and diagnostic tests, critically summarizing and analyzing the evidence form prognosis studies in a systematic review and meta analysis is beneficial for health care professionals seeking the best evidence.

About this course

• A BSc or MSc degree in biomedical sciences, pharmaceutical sciences, medicine or veterinary medicine, or a comparable degree
• Access to the program R
• We strongly recommend that you take part in our online course Prognostic Research, prior to enrolling in this course
• Sufficient proficiency in English reading and writing

Questions & Answers

Add your question

Our advisors and other users will be able to reply to you

Who would you like to address this question to?

Fill in your details to get a reply

We will only publish your name and question

Reviews

Subjects

  • Primary
  • Rationale
  • Prognostic
  • Systematic
  • Focused
  • Prognostic problem
  • Systematically
  • Literature
  • Meta-analysis
  • Analyses

Course programme

By the end of the course, you'll should be able to:
  • Explain the rationale for performing a systematic review of prognostic studies
  • List the key steps of a systematic review of prognostic studies
  • Formulate a focused review question addressing a prognostic problem
  • Systematically search the literature
  • Critically appraise the evidence from primary prognostic studies
  • Formulate the difficulties of meta-analysis of prognostic research
  • Meta-analyses of performance of prognostic models
  • Meta-analyses of the added value of specific prognostic factors

Systematic Reviews and Meta-Analysis of Prognosis Research

£ 785 VAT inc.